{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:22:02Z","timestamp":1790767322342,"version":"4.1.0"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["5R01HL478946"],"award-info":[{"award-number":["5R01HL478946"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health\u2013Pharmacogenomics Research Network\u2013Riken Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pulmonary arterial hypertension (PAH) is a progressive fatal disease. Variable response and tolerability to PAH therapeutics suggests that genetic differences may influence outcomes. The endothelin pathway is central to pulmonary vascular function, and several polymorphisms and\/or mutations in the genes coding for endothelin (ET)-1 and its receptors correlate with the clinical manifestations of other diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the interaction of ET-1 pathway polymorphisms and treatment responses of patients with PAH treated with ET receptor antagonists (ERAs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 1,198 patients with PAH were prospectively enrolled from 45 U.S. and Canadian pulmonary hypertension centers or retrospectively from global sites participating in the STRIDE (Sitaxsentan To Relieve Impaired Exercise) trials. Comprehensive objective measures including a 6-minute-walk test, Borg dyspnea score, functional class, and laboratory studies were completed at baseline, before the initiation of ERAs, and repeated serially. Single-nucleotide polymorphisms from ET-1 pathway candidate genes were selected from a completed genome-wide association study performed on the study cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Patient efficacy outcomes were analyzed for a relationship between ET-1 pathway polymorphisms and clinical efficacy using predefined, composite positive and negative outcome measures in 715 European descent samples. A single-nucleotide polymorphism (rs11157866) in the G-protein alpha and gamma subunits gene was significantly associated, accounting for multiple testing, with a combined improvement in functional class and 6-minute-walk distance at 12 and 18 months and marginally significant at 24 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ET-1 pathway associated polymorphisms may influence the clinical efficacy of ERA therapy for PAH. Further prospective studies are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201501-0196oc","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T14:52:04Z","timestamp":1438959124000},"page":"1345-1354","source":"Crossref","is-referenced-by-count":96,"title":["Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension"],"prefix":"10.1093","volume":"192","author":[{"given":"Raymond L.","family":"Benza","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mardi","family":"Gomberg-Maitland","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Demarco","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaani E.","family":"Frost","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, ECZ, Otwock, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Langleben","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Pulido","sequence":"additional","affiliation":[{"name":"Cardiopulmonary Department, National Heart Institute, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Correa-Jaque","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Passineau","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Disease, Department of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard W.","family":"Wiener","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Tamari","sequence":"additional","affiliation":[{"name":"Institute of Physical and Chemical Research (RIKEN), Center for Integrative Medical Sciences, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Hirota","sequence":"additional","affiliation":[{"name":"Institute of Physical and Chemical Research (RIKEN), Center for Integrative Medical Sciences, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Kubo","sequence":"additional","affiliation":[{"name":"Institute of Physical and Chemical Research (RIKEN), Center for Integrative Medical Sciences, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K.","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"2026032100122489900_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"2026032100122489900_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"key":"2026032100122489900_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCRESAHA.115.301132","article-title":"Pulmonary arterial hypertension: yesterday, today, tomorrow","volume":"115","author":"Michelakis","year":"2014","journal-title":"Circ Res"},{"key":"2026032100122489900_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.201304-0686PP","article-title":"Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension","volume":"188","author":"Klinger","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100122489900_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1164\/rccm.201303-0470UP","article-title":"Update in pulmonary vascular diseases 2012","volume":"188","author":"Wilkins","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100122489900_bib6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1183\/09031936.00046612","article-title":"Pathobiology of pulmonary arterial hypertension and right ventricular failure","volume":"40","author":"Voelkel","year":"2012","journal-title":"Eur Respir J"},{"key":"2026032100122489900_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/01.RES.69.1.209","article-title":"Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes","volume":"69","author":"Ito","year":"1991","journal-title":"Circ Res"},{"key":"2026032100122489900_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.32.1.89","article-title":"Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression","volume":"32","author":"Matsuura","year":"1998","journal-title":"Hypertension"},{"key":"2026032100122489900_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/bbrc.1997.7940","article-title":"Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells","volume":"242","author":"Peifley","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2026032100122489900_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0021-9150(90)90118-3","article-title":"The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells","volume":"85","author":"Weissberg","year":"1990","journal-title":"Atherosclerosis"},{"key":"2026032100122489900_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.CIR.100.1.5","article-title":"Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade","volume":"100","author":"Yang","year":"1999","journal-title":"Circulation"},{"key":"2026032100122489900_bib12","doi-asserted-by":"crossref","first-page":"20555","DOI":"10.1016\/S0021-9258(17)30538-0","article-title":"Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy","volume":"265","author":"Shubeita","year":"1990","journal-title":"J Biol Chem"},{"key":"2026032100122489900_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biocel.2014.06.020","article-title":"Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent","volume":"54","author":"Biasin","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"2026032100122489900_bib14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"2026032100122489900_bib15","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.CIR.84.6.2280","article-title":"Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation","volume":"84","author":"Yoshibayashi","year":"1991","journal-title":"Circulation"},{"key":"2026032100122489900_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart","year":"1991","journal-title":"Ann Intern Med"},{"key":"2026032100122489900_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00296-013-2861-6","article-title":"Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy","volume":"34","author":"Kawashiri","year":"2014","journal-title":"Rheumatol Int"},{"key":"2026032100122489900_bib18","first-page":"718","article-title":"Changes in plasma levels of atrial natriuretic peptide, endothelin-1 and von Willebrand factor among newborns with persistent pulmonary hypertension [in Chinese]","volume":"15","author":"Yao","year":"2013","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"2026032100122489900_bib19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0735-1097(95)00399-1","article-title":"Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels","volume":"26","author":"Nootens","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"2026032100122489900_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"2026032100122489900_bib21","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.jacc.2013.10.031","article-title":"Updated treatment algorithm of pulmonary arterial hypertension","volume":"62","author":"Gali\u00e8","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026032100122489900_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijcard.2013.12.179","article-title":"Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients","volume":"172","author":"Simonneau","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026032100122489900_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Gali\u00e9","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026032100122489900_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"2026032100122489900_bib25","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"2026032100122489900_bib26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"2026032100122489900_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"2026032100122489900_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.11-0404","article-title":"Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension","volume":"141","author":"Gabler","year":"2012","journal-title":"Chest"},{"key":"2026032100122489900_bib29","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/00005344-200000002-00010","article-title":"Association between diastolic blood pressure and variants of the endothelin-1 and endothelin-2 genes","volume":"35","author":"Brown","year":"2000","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026032100122489900_bib30","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0895-7061(98)00255-6","article-title":"Polymorphisms of the endothelin-A and -B receptor genes in relation to blood pressure and myocardial infarction: the Etude Cas-T\u00e9moins sur l\u2019Infarctus du Myocarde (ECTIM) Study","volume":"12","author":"Nicaud","year":"1999","journal-title":"Am J Hypertens"},{"key":"2026032100122489900_bib31","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1053\/euhj.2001.2626","article-title":"A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy","volume":"22","author":"Herrmann","year":"2001","journal-title":"Eur Heart J"},{"key":"2026032100122489900_bib32","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199526003-00004","article-title":"Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension","volume":"26","author":"Stevens","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026032100122489900_bib33","first-page":"169","article-title":"The association of genetic variations with sensitivity of blood pressure to dietary salt: a narrative literature review","volume":"10","author":"Doaei","year":"2014","journal-title":"ARYA Atheroscler"},{"key":"2026032100122489900_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-1-4939-0956-8_9","article-title":"Pharmacogenetics of the G protein-coupled receptors","volume":"1175","author":"Thompson","year":"2014","journal-title":"Methods Mol Biol"},{"key":"2026032100122489900_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-0956-8_7","article-title":"G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insights","volume":"1175","author":"Thompson","year":"2014","journal-title":"Methods Mol Biol"},{"key":"2026032100122489900_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pupt.2011.10.002","article-title":"Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension","volume":"25","author":"Sandoval","year":"2012","journal-title":"Pulm Pharmacol Ther"},{"key":"2026032100122489900_bib37","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1378\/chest.07-0767","article-title":"Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survival","volume":"134","author":"Benza","year":"2008","journal-title":"Chest"},{"key":"2026032100122489900_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.healun.2006.10.019","article-title":"Sitaxsentan treatment for patients with pulmonary arterial hypertension discontinuing bosentan","volume":"26","author":"Benza","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"2026032100122489900_bib39","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026032100122489900_bib40","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/01.fjc.0000166207.74178.d0","article-title":"STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials","volume":"44","author":"Langleben","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026032100122489900_bib41","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/ng.3045","article-title":"A genome-wide association study identifies susceptibility loci for ossification of the posterior longitudinal ligament of the spine","volume":"46","author":"Nakajima","year":"2014","journal-title":"Nat Genet"},{"key":"2026032100122489900_bib42","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/ddu512","article-title":"Genome-wide association study identified SNP on 15q24 associated with bladder cancer risk in Japanese population","volume":"24","author":"Matsuda","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2026032100122489900_bib43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gepi.20516","article-title":"Quality control and quality assurance in genotypic data for genome-wide association studies","volume":"34","author":"Laurie","year":"2010","journal-title":"Genet Epidemiol"},{"key":"2026032100122489900_bib44","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2026032100122489900_bib45","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/bioinformatics\/btq559","article-title":"Robust relationship inference in genome-wide association studies","volume":"26","author":"Manichaikul","year":"2010","journal-title":"Bioinformatics"},{"key":"2026032100122489900_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1086\/383251","article-title":"A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other","volume":"74","author":"Nyholt","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2026032100122489900_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","article-title":"Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix","volume":"95","author":"Li","year":"2005","journal-title":"Heredity (Edinb)"},{"key":"2026032100122489900_bib48","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1164\/rccm.201203-0480OC","article-title":"The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension","volume":"186","author":"Mathai","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100122489900_bib49","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026032100122489900_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"2026032100122489900_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000064976","article-title":"Trend tests for case-control studies of genetic markers: power, sample size and robustness","volume":"53","author":"Freidlin","year":"2002","journal-title":"Hum Hered"},{"key":"2026032100122489900_bib52","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1006\/bbrc.2000.2832","article-title":"Cloning, characterization, and mapping of the gene encoding the human G protein gamma 2 subunit","volume":"272","author":"Modarressi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2026032100122489900_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jdermsci.2012.09.009","article-title":"Functional analysis of GNG2 in human malignant melanoma cells","volume":"68","author":"Yajima","year":"2012","journal-title":"J Dermatol Sci"},{"key":"2026032100122489900_bib54","first-page":"182","article-title":"GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity","volume":"4","author":"Yajima","year":"2014","journal-title":"Am J Cancer Res"},{"key":"2026032100122489900_bib55","first-page":"322","article-title":"Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines","volume":"2","author":"Yajima","year":"2012","journal-title":"Am J Cancer Res"},{"key":"2026032100122489900_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2005-09-3706","article-title":"Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis","volume":"108","author":"Leung","year":"2006","journal-title":"Blood"},{"key":"2026032100122489900_bib57","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.cellsig.2011.05.015","article-title":"Central and C-terminal domains of heterotrimeric G protein gamma subunits differentially influence the signaling necessary for primordial germ cell migration","volume":"23","author":"Mulligan","year":"2011","journal-title":"Cell Signal"},{"key":"2026032100122489900_bib58","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20081561","article-title":"-Arrestin1 interacts with the G-protein subunits \u03b21\u03b32 and promotes \u03b21\u03b32-dependent Akt signalling for NF-\u03baB activation","volume":"417","author":"Yang","year":"2009","journal-title":"Biochem J"},{"key":"2026032100122489900_bib59","doi-asserted-by":"crossref","first-page":"24293","DOI":"10.1074\/jbc.M100089200","article-title":"Regulator of G-protein signaling 3 (RGS3) inhibits Gbeta1gamma 2-induced inositol phosphate production, mitogen-activated protein kinase activation, and Akt activation","volume":"276","author":"Shi","year":"2001","journal-title":"J Biol Chem"},{"key":"2026032100122489900_bib60","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2217\/pgs.13.226","article-title":"Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes","volume":"15","author":"Matimba","year":"2014","journal-title":"Pharmacogenomics"},{"key":"2026032100122489900_bib61","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.4238\/2014.July.24.26","article-title":"Molecular cloning and expression analysis of the GNAS gene in pig and porcine fibroblast cells","volume":"13","author":"Peng","year":"2014","journal-title":"Genet Mol Res"},{"key":"2026032100122489900_bib62","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1210\/en.2004-0865","article-title":"Minireview: GNAS: normal and abnormal functions","volume":"145","author":"Weinstein","year":"2004","journal-title":"Endocrinology"},{"key":"2026032100122489900_bib63","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/0008-5472.CAN-03-2089","article-title":"A pivotal role of cyclic AMP-responsive element binding protein in tumor progression","volume":"64","author":"Abramovitch","year":"2004","journal-title":"Cancer Res"},{"key":"2026032100122489900_bib64","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.canlet.2013.02.042","article-title":"Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK\/STAT pathway","volume":"335","author":"Follin-Arbelet","year":"2013","journal-title":"Cancer Lett"},{"key":"2026032100122489900_bib65","doi-asserted-by":"crossref","first-page":"H2015","DOI":"10.1152\/ajpheart.00738.2009","article-title":"Differential regulation of vascular smooth muscle and endothelial cell proliferation in vitro and in vivo by cAMP\/PKA-activated p85alphaPI3K","volume":"297","author":"Torella","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026032100122489900_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1465-9921-7-9","article-title":"Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells","volume":"7","author":"Growcott","year":"2006","journal-title":"Respir Res"},{"key":"2026032100122489900_bib67","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.HYP.35.1.237","article-title":"Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21","volume":"35","author":"Hayashi","year":"2000","journal-title":"Hypertension"},{"key":"2026032100122489900_bib68","first-page":"291","article-title":"Inhibition of vascular smooth muscle cell proliferation by endothelium-dependent vasodilators","volume":"17","author":"Newby","year":"1992","journal-title":"Herz"},{"key":"2026032100122489900_bib69","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1016\/j.amjcard.2012.12.002","article-title":"Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies","volume":"111","author":"Waxman","year":"2013","journal-title":"Am J Cardiol"},{"key":"2026032100122489900_bib70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-3-642-38664-0_8","article-title":"Prostacyclins","volume":"218","author":"Olschewski","year":"2013","journal-title":"Handbook Exp Pharmacol"},{"key":"2026032100122489900_bib71","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.08.004","article-title":"Endothelins induce ETB receptor-mediated mechanical hypernociception in rat hindpaw: roles of cAMP and protein kinase C","volume":"501","author":"da Cunha","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"2026032100122489900_bib72","doi-asserted-by":"crossref","first-page":"e98718","DOI":"10.1371\/journal.pone.0098718","article-title":"Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation","volume":"9","author":"Takano","year":"2014","journal-title":"PLoS One"},{"key":"2026032100122489900_bib73","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/onc.2013.202","article-title":"An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer","volume":"33","author":"Garcia-Murillas","year":"2014","journal-title":"Oncogene"},{"key":"2026032100122489900_bib74","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1053\/j.gastro.2014.03.025","article-title":"Molecular changes leading to gastric cancer: a suggestion from rare-type gastric tumors with GNAS mutations","volume":"146","author":"Ikuta","year":"2014","journal-title":"Gastroenterology"},{"key":"2026032100122489900_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/JME-13-0297","article-title":"Three intragenic suppressors of a GTPase-deficient allele of GNAS associated with McCune-Albright syndrome","volume":"52","author":"Turcic","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"2026032100122489900_bib76","doi-asserted-by":"crossref","first-page":"e60525","DOI":"10.1371\/journal.pone.0060525","article-title":"Quantitative and sensitive detection of GNAS mutations causing McCune-Albright syndrome with next generation sequencing","volume":"8","author":"Narumi","year":"2013","journal-title":"PLoS One"},{"key":"2026032100122489900_bib77","first-page":"321","article-title":"Association between GNAS1 T393C polymorphism and therapeutic efficacy of tyrosine kinase inhibitor in pretreated advanced non-small cell lung cancer with unknown EGFR mutation status [in Chinese]","volume":"17","author":"Hong","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"2026032100122489900_bib78","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1245\/s10434-014-3843-y","article-title":"Homozygous GNAS 393C-allele carriers with locally advanced esophageal cancer fail to benefit from platinum-based preoperative chemoradiotherapy","volume":"21","author":"Alakus","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"2026032100122489900_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.molcel.2012.10.018","article-title":"A genome-wide RNAi screen reveals a Trio-regulated Rho GTPase circuitry transducing mitogenic signals initiated by G protein-coupled receptors","volume":"49","author":"Vaqu\u00e9","year":"2013","journal-title":"Mol Cell"},{"key":"2026032100122489900_bib80","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.1074\/jbc.M112.437749","article-title":"MicroRNA-182 and microRNA-200a control G-protein subunit \u03b1-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells","volume":"288","author":"Rasheed","year":"2013","journal-title":"J Biol Chem"},{"key":"2026032100122489900_bib81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/08916934.2011.637531","article-title":"Angiogenesis-related gene expression analysis in celiac disease","volume":"45","author":"Castellanos-Rubio","year":"2012","journal-title":"Autoimmunity"},{"key":"2026032100122489900_bib82","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng.2581","article-title":"Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension","volume":"45","author":"Germain","year":"2013","journal-title":"Nat Genet"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/11\/1345\/67230822\/ajrccm_192_11_1345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/11\/1345\/67230822\/ajrccm_192_11_1345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:12:37Z","timestamp":1774066357000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/192\/11\/1345\/8504579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":82,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,12,1]]},"published-print":{"date-parts":[[2015,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201501-0196oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,12]]},"published":{"date-parts":[[2015,12,1]]}}}